Literature DB >> 16018852

Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension.

Costas Tsioufis1, Pavlos Stougiannos, Apostolis Kakkavas, Marina Toutouza, Argiris Mariolis, Ioannis Vlasseros, Christodoulos Stefanadis, Ioannis Kallikazaros.   

Abstract

In this study, we investigated possible relations between left ventricular (LV) concentric remodeling and plasma levels of high-sensitivity C-reactive protein (hs-CRP) and serum amyloid-A (SAA) in subjects who had essential hypertension; 65 consecutive subjects who had hypertension, did not have diabetes, and had normal LV mass were categorized as those whose LV relative wall thickness was <0.44 (n = 41) and those whose relative wall thickness was > or =0.44. Venous blood samples were collected for determination of metabolic profile and plasma levels of hs-CRP and SAA. Subjects whose relative LV wall thickness was > or =0.44 compared with those whose relative LV wall thickness was <0.44 had significantly increased systolic blood pressure by 4.5 mm Hg (p = 0.015) and higher levels of plasma hs-CRP (1.80 vs 1.39 mg/L, p = 0.001) and SAA (10.22 vs 4.86 mg/dl, p = 0.000), although the 2 groups did not differ with regard to age, gender, waist-to-hip ratio, and diastolic blood pressure (p = NS for all). In the entire study population, log hs-CRP and SAA exhibited positive relations with systolic blood pressure (r = 0.21 and r = 0.29, respectively; p <0.05 for the 2 markers) and relative wall thickness (r = 0.26 and r = 0.81, respectively; p <0.05 for the 2 markers). Multiple linear regression analysis showed that age, gender, and diastolic blood pressure were significantly associated with LV mass index (p <0.05), whereas gender, body mass index, log hs-CRP, and SAA were significantly associated with relative wall thickness (p <0.003). By analysis of covariance, log hs-CRP and SAA were significantly different between subjects whose relative LV wall thickness was > or =0.44 and those whose relative LV wall thickness was <0.44 after the adjustment for age, gender, body mass index, and systolic/diastolic blood pressure (p <0.005 for the 2 markers). In conclusion, alterations in LV geometry are associated with increased serum CRP and SAA levels in patients who are newly diagnosed with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018852     DOI: 10.1016/j.amjcard.2005.03.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study.

Authors:  Michael O Harhay; Russell P Tracy; Emilia Bagiella; R Graham Barr; Diane Pinder; W Gregory Hundley; David A Bluemke; Richard A Kronmal; Joao A C Lima; Steven M Kawut
Journal:  Int J Cardiol       Date:  2013-08-09       Impact factor: 4.164

2.  l -Arginine Can Enhance the Beneficial Effect of Losartan in Patients with Chronic Aortic Regurgitation and Isolated Systolic Hypertension.

Authors:  Shoa-Lin Lin; Mike Lin; Kuei-Liang Wang; Hsien-Wen Kuo; Tahir Tak
Journal:  Int J Angiol       Date:  2021-05-11

3.  Systemic Action of Inflammatory Mediators in Patients with Essential Hypertension and Diastolic Chronic Heart Failure: A Clinical Pathophysiological Study.

Authors:  Anton V Barsukov; Alla Yu Seidova; Ksenia A Shcherbakova; Marina S Black; Alexander E Korovin; Leonid P Churilov; Dmitry V Tovpeko
Journal:  Pathophysiology       Date:  2020-12-12

4.  Heart Dysfunction in Essential Hypertension Depends on Systemic Proinflammatory Influences: A Retrospective Clinical Pathophysiological Study.

Authors:  Anton V Barsukov; Alexander E Korovin; Leonid P Churilov; Ekaterina V Borisova; Dmitry V Tovpeko
Journal:  Pathophysiology       Date:  2022-08-07

5.  The Relationship Between High-Sensitivity C-Reactive Protein Levels and Left Ventricular Hypertrophy in Patients With Newly Diagnosed Hypertension.

Authors:  Ergun Seyfeli; Bahadir Sarli; Hayrettin Saglam; Can Y Karatas; Eyup Ozkan; Mehmet Ugurlu
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-24       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.